Tramadol
CAS Number:
27203-92-5
Batch Molecular Formula:
C16H25NO2
Batch Molecular Weight:
263.381 g/mol
Physical Appearance:
White Crystalline Powder
Solubility:
Soluble in Water and Ethanol
Storage:
Store at RT
Tramadol API is a centrally acting synthetic analgesic used for the management of moderate to moderately severe pain. It works through opioid receptor activity and by inhibiting the reuptake of serotonin and norepinephrine, helping reduce the transmission of pain signals.
Tramadol formulations can be categorized into the following classifications:
1. Medical Pharmaceutical Formulations
Immediate-Release (IR):
Acute Pain Management: Provides faster pain relief for acute and moderate pain.
Duration: Typically 4–6 hours.
Extended-Release (ER):
Chronic Pain Management: Designed for longer-term management of chronic pain.
Duration: Typically 12–24 hours.
Administration: Often taken once daily as directed.
2. Combination Products
Tramadol may be combined with other active pharmaceutical ingredients (APIs) to provide enhanced pain control.
Tramadol + Acetaminophen (Paracetamol): Used for pain management when combination therapy is clinically appropriate.
3. Dosage Forms
Tablets
Capsules
Injectable Solutions
Liquid Solutions
Axim Pharma – Tramadol API Manufacturer & Contract Manufacturer in India
Axim Pharma is a trusted Tramadol API manufacturer and contract manufacturer in India, serving pharmaceutical customers across Africa, China, Turkey, Hong Kong, the USA, Europe, and other international markets. We offer custom manufacturing, bulk API supply, competitive pricing, and seamless logistics tailored to your requirements.
Partner with Axim Pharma for high-quality Tramadol API production, custom synthesis, bulk supply, and global distribution, supporting consistent quality and compliance with applicable requirements across international markets.
Contact our sales team today for personalized quotations and efficient delivery solutions.
Effects
1. Short-term Positive Effects
Pain relief (especially moderate pain).
Mild euphoria or sense of wellbeing (in some people).
Relaxation and sedation.
2. Short-term Negative Effects
Drowsiness, dizziness, and impaired coordination.
Nausea, vomiting, constipation, and dry mouth.
Confusion, sweating, and itching.
Risk of seizures
Risk of serotonin syndrome
3. Long-term Effects
Dependence and addiction.
Tolerance (needing higher doses to get the same effect).
Mood changes and mental health issues (e.g., depression, irritability).
Usage
1. Therapeutic Effects:
Relieves moderate to moderately severe pain by acting on opioid receptors and inhibiting reuptake of serotonin and norepinephrine.
Improves physical functioning and comfort in conditions such as post-operative pain, injury-related pain, or chronic pain (when appropriately prescribed).
2. Side Effects:
Common:
Nausea, vomiting, and constipation.
Drowsiness, dizziness, and fatigue.
Headache, dry mouth, and sweating.
Less Common:
Itching (pruritus) and flushing.
Mood changes (e.g., irritability, anxiety).
Blurred vision or difficulty concentrating.
3. Serious Adverse Effects:
Respiratory depression on higher doses.
Seizures on higher doses.
Disclaimer
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Axim Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Axim Pharmaceutical India is not responsible or liable for the same.
